DAMIANO, Rocco
 Distribuzione geografica
Continente #
NA - Nord America 3.537
AS - Asia 2.168
EU - Europa 1.030
SA - Sud America 435
AF - Africa 48
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 4
Totale 7.228
Nazione #
US - Stati Uniti d'America 3.386
SG - Singapore 1.013
CN - Cina 542
IT - Italia 436
BR - Brasile 343
IN - India 251
VN - Vietnam 174
GB - Regno Unito 152
SE - Svezia 122
CA - Canada 115
DE - Germania 105
FI - Finlandia 47
HK - Hong Kong 45
AR - Argentina 35
JP - Giappone 29
FR - Francia 26
ID - Indonesia 24
MX - Messico 24
UA - Ucraina 21
BD - Bangladesh 19
ZA - Sudafrica 19
NL - Olanda 18
PL - Polonia 16
EC - Ecuador 15
RU - Federazione Russa 15
CO - Colombia 12
ES - Italia 12
CZ - Repubblica Ceca 11
AE - Emirati Arabi Uniti 9
RO - Romania 9
TR - Turchia 9
IQ - Iraq 8
PY - Paraguay 8
AT - Austria 7
AZ - Azerbaigian 7
BE - Belgio 7
CH - Svizzera 7
EG - Egitto 7
MA - Marocco 7
CL - Cile 6
EU - Europa 6
JM - Giamaica 6
PE - Perù 6
VE - Venezuela 5
LB - Libano 4
LT - Lituania 4
TW - Taiwan 4
UZ - Uzbekistan 4
AU - Australia 3
IL - Israele 3
IR - Iran 3
KE - Kenya 3
KR - Corea 3
NO - Norvegia 3
OM - Oman 3
UY - Uruguay 3
AO - Angola 2
BO - Bolivia 2
BY - Bielorussia 2
DK - Danimarca 2
EE - Estonia 2
HN - Honduras 2
IE - Irlanda 2
MY - Malesia 2
RS - Serbia 2
SA - Arabia Saudita 2
TN - Tunisia 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DZ - Algeria 1
ET - Etiopia 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
SC - Seychelles 1
SD - Sudan 1
SN - Senegal 1
TH - Thailandia 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
ZW - Zimbabwe 1
Totale 7.228
Città #
Chandler 514
Dallas 463
Singapore 296
Santa Clara 210
Hefei 202
Bengaluru 201
Milan 199
Princeton 186
Lawrence 185
London 121
Chicago 118
Ashburn 116
Wilmington 109
Ottawa 86
Beijing 78
Munich 76
Des Moines 65
Ho Chi Minh City 62
Boardman 47
Los Angeles 46
Hong Kong 43
The Dalles 39
Catanzaro 38
Hanoi 38
Columbus 37
São Paulo 33
Turku 31
New York 30
Council Bluffs 26
Shanghai 22
Tokyo 21
Brooklyn 19
Guangzhou 16
Helsinki 16
Norwalk 16
Pune 16
Rome 16
Warsaw 16
Boston 15
Shenzhen 15
Bagneux 14
West Jordan 12
Falls Church 11
Montreal 11
Olomouc 11
Redmond 11
San Francisco 11
Seattle 11
Toronto 11
Altavilla Irpina 10
Ann Arbor 10
Houston 10
Johannesburg 10
Stockholm 10
Wuhan 10
Rio de Janeiro 9
Atlanta 8
Curitiba 8
Da Nang 8
Florence 8
Haiphong 8
Hanover 8
Amsterdam 7
Baku 7
Chennai 7
Fairfield 7
Redwood City 7
Charlotte 6
Denver 6
Goiânia 6
Guayaquil 6
Manaus 6
Phoenix 6
Ankara 5
Augusta 5
Biên Hòa 5
Bologna 5
Brasília 5
Guarulhos 5
Jakarta 5
Kingston 5
Manchester 5
Mexico City 5
Moscow 5
Raleigh 5
Rui'an 5
Santo André 5
Washington 5
Zurich 5
Bắc Giang 4
Cluj-Napoca 4
Dubai 4
Ferrara 4
Fortaleza 4
Ha Long 4
Laferrere 4
Lima 4
Mauá 4
Messina 4
Orangeburg 4
Totale 4.298
Nome #
64CuCl2 PET/CT as a potential new imaging method in prostate cancer: illusion or reality? 99
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study 87
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 74
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 74
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor. 73
Effects of One-Shot Hyaluronic Acid Injection in Lifelong Premature Ejaculation: A Pilot Study 73
Adaptation and validation of an Italian version of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI). 72
Adrenal sparing surgery in the treatment of renal cell carcinoma: when is it possible. R. Autorino, G. De Lorenzo 71
Visceral obesity predicts adverse pathological features in urothelial bladder cancer patients undergoing radical cystectomy: a retrospective cohort study. 70
Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer: A systematic review. 70
A larger detrusor wall thickness increases the risk of non muscle invasive bladder cancer recurrence and progression: result from a multicenter observational study. 67
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer. 67
Comparison Between (64)Cu-PSMA-617 PET/CT and (18)F-Choline PET/CT Imaging in Early Diagnosis of Prostate Cancer Biochemical Recurrence. 65
An alternative approach for the identification of potential prostate cancer biomarkers 65
Altered Metalloproteinase-9 expression as the least common denominator between Varicocele, Inguinal Hernia and Chronic Venous Disorders 64
Adrenalectomy: defining its role in the surgical treatment of renal cell carcinoma 62
Active Surveillance for Low-risk Prostate Cancer: Are All Criteria Similar? 61
Metabolic syndrome in white European men presenting for primary couple's infertility: investigation of the clinical and reproductive burden. 61
30. How to decrease pain during transrectal ultrasound guided prostate biopsy: a look at the literature 60
8. Early and late complications of ureteral stent 60
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy 60
Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy. 59
Long-term recovery of normal sexual function in testicular cancer survivors. 59
Detection Rate of Prostate-Specific Membrane Antigen Tracers for Positron Emission Tomography/Computed Tomography in Prostate Cancer Biochemical Recurrence: A Systematic Review and Network Meta-Analysis 58
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non-muscle-invasive Bladder Cancer. 57
PSA and PSA Kinetics as Predictors for 18F-Fluciclovine PET/CT Positivity in Biochemically Recurrent Prostate Cancer 57
Contemporary urologic minilaparoscopy: indications, techniques, and surgical outcomes in a multi-institutional European cohort. 56
Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experience. 56
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer 55
High-throughput detection of low abundance sialylated glycoproteins in human serum by TiO2 enrichment and targeted LC-MS/MS analysis: application to a prostate cancer sample set 54
An update on prostate biopsy in the era of magnetic resonance imaging 53
Multiparametric magnetic resonance imaging and active surveillance: How to better select insignificant prostate cancer? 53
Prostate Cancer Detection in the "Grey Area" of Prostate-Specific Antigen Below 10 ng/ml: Head-to-Head Comparison of the Updated PCPT Calculator and Chun's Nomogram, Two Risk Estimators Incorporating Prostate Cancer Antigen 3 53
5. Prevalence of faecal incontinence among women with urinary incontinence 51
Are abstracts presented at the EAU Meeting followed by fublications in peer Reviewed Journals? 51
Are extended biopsies really necessary to improve prostate cancer detection? 51
The impact the COVID-19 pandemic on urology literature: a bibliometric analysis 50
Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer : a multi-institutional, long-term experience 50
Fate of abstracts presented at the World Congress of Endourology: are they followed by pubblication in peer-reviewed journals? 50
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG 49
Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy. 49
Metabolic syndrome correlates with peri-urethral fibrosis secondary to chronic prostate inflammation: evidence of a link in a cohort of patients undergoing radical prostatectomy. 49
Robot-assisted Radical Nephrectomy: A Systematic Review and Meta-analysis of Comparative Studies 49
Mechanical and Ablative Minimally Invasive Techniques for Male LUTS due to Benign Prostatic Obstruction: A Systematic Review according to BPH-6 Evaluation 48
Latest Evidence On The Role Of Multiparametric Magnetic Resonance Imaging In Active Surveillance For Insignificant Prostate Cancer: A Systematic Review 47
Avanafil - a further step to tailoring patient needs and expectations. 47
Questionnaire based evaluation of prostate cancer biopsy complication comparing different bioptic schemes 47
Evaluation of accuracy and reproducibility of a novel method for measuring penile curvature in Peyronie’s disease: the Check Him mobile application 47
Awareness and knowledge of human papillomavirus-related diseases are still dramatically insufficient in the era of high-coverage vaccination programs. 46
Beyond PSA: The role of prostate health index (phi) 46
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies 46
Management of renal cell carcinoma in transplant kidney: a systematic review and meta-analysis 45
Pelvic lymph node dissection in prostate cancer: indications, extent and tailored approaches. 45
Economic evaluation of a new non-antibiotic 1st-line treatment of rUTI 45
Prevalence and predictors of concomitant low sexual desire/interest and new-onset erectile dysfunction - a picture from the everyday clinical practice. 44
Intravesical treatment with highly-concentrated hyaluronic acid and chondroitin sulphate in patients with recurrent urinary tract infections: Results from a multicentre survey. 44
Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution. 44
Results and complications of laparoscopic surgery for pediatric varicocele. 44
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 44
Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy 43
Predictors of Residual T1 High Grade on Re-Transurethral Resection in a Large Multi-Institutional Cohort of Patients with Primary T1 High-Grade/Grade 3 Bladder Cancer 43
The Role of Molecular Imaging in a Muscle-Invasive Bladder Cancer Patient: A Narrative Review in the Era of Multimodality Treatment 43
The impact of sars-cov-2 pandemic on time to primary, secondary resection and adjuvant intravesical therapy in patients with high-risk non-muscle invasive bladder cancer: A retrospective multi-institutional cohort analysis 43
Lower urinary tract symptoms among Caucasian-European men who have sex with men: findings from a real-life survey. 42
Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance 42
Importance of prostate volume in the stratification of patients with intermediate-risk prostate cancer. 42
Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: an evidence-based analysis 42
Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies 42
Estimated Glomerular Filtration Rate Decline at 1 Year After Minimally Invasive Partial Nephrectomy: A Multimodel Comparison of Predictors 41
Retropubic, laparoscopic and mini-laparoscopic radical prostatectomy: a prospective assessment of patient scar satisfaction. 41
Metabolic syndrome diagnosis and widespread high grade prostatic intraepithelial neoplasia significantly increase prostate cancer risk: results from a multicenter biopsy study. 41
Elective conservative surgery for renal carcinoma versus radical nephrectomy: a prospective study. 41
Secondary provoked vestibulodynia in sexually active women with uncomplicated recurrent urinary tract infecti 41
Haemostatic agents during laparoscopic nephron-sparing surgery: what about TachoSil? 41
Diagnostic Accuracy of (64)Copper Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging of Intermediate- to High-risk Prostate Cancer: Our Preliminary Experience 41
The presence of carcinoma in situ at radical cystectomy increases the risk of urothelial recurrence: Implications for follow-up schemes. 40
The emerging role of obesity, diet and lipid metabolism in prostate cancer Targeted proteomic approach in prostatic tissue: a panel of potential biomarkers for cancer detection 40
Needle biopsy size and pathological Gleason Score diagnosis: No evidence for a link. 40
Hypovitaminosis D and low urinary tract symptoms in a female population 40
Incidence and Predictors of 30-Day Readmission After Robot-Assisted Radical Prostatectomy. 40
Quality of life in women with multiple sclerosis and overactive bladder syndrome 40
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer 39
Patients with metabolic syndrome and widespread high grade prostatic intraepithelial neoplasia are at a higher risk factor of prostate cancer on re-biopsy: a prospective single cohort study. 39
Periurethral fibrosis secondary to prostatic inflammation causing lower urinary tract symptoms: a prospective cohort study 39
Sperm banking is of key importance in patients with prostate cancer. 39
Metabolic Syndrome, Obesity, and Radical Cystectomy Complications: A Clavien Classification System-Based Analysis. 39
One patient out of four with newly diagnosed erectile dysfunction is a young man-worrisome picture from the everyday clinical practice. 39
Restoring the glycosaminoglycans layer in recurrent cystitis: Experimental and clinical foundations 39
Pelvic plexus block is more effective than periprostatic nerve block for pain control during office transrectal ultrasound guided prostate biopsy: A single center, prospective, randomized, double arm study 39
Experience with the use of tissue adhesives in pediatric endoscopic surgery 39
Proteomic Profile of EPS-Urine through FASP Digestion and Data-Independent Analysis 39
Sexual outcome following photoselective vaporization of the prostate: is there enough evidence? 38
Three-dimensional vs standard laparoscopy: comparative assessment using a validated program for laparoscopic urologic skills. 38
Targeted proteomic approach in prostatic tissue: a panel of potential biomarkers for cancer detection 38
Reporting quality of abstract s presented at the European association of urology meeting: a critical assessment 38
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance 38
Stent positioning after ureteroscopy for urinary calculi: the question is still open 38
Extent of lymph node dissection and impact on survival in radical cystectomy for advanced bladder cancer 37
Comparison between five different hormonal treatment protocols for children with cryptorchidism 37
External validation of the european Association of Urology recommendations for lymph node dissection in patients treated with robotic-assisted radical prostatectomy. 37
Totale 4.991
Categoria #
all - tutte 84.882
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.882


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021123 0 0 0 0 0 16 6 14 48 21 7 11
2021/2022837 4 2 7 471 11 10 28 108 61 28 86 21
2022/20231.564 377 26 46 133 190 142 94 111 249 87 95 14
2023/2024622 140 88 50 37 31 149 14 21 12 23 14 43
2024/20252.062 288 204 99 56 92 249 40 97 278 133 219 307
2025/20262.328 224 558 500 634 410 2 0 0 0 0 0 0
Totale 7.737